Penkert, R.R.; Chandramouli, S.; Dormitzer, P.R.; Settembre, E.C.; Sealy, R.E.; Wong, S.; Young, N.S.; Sun, Y.; Tang, L.; Cotton, A.;
et al. Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease. Vaccines 2021, 9, 860.
https://doi.org/10.3390/vaccines9080860
AMA Style
Penkert RR, Chandramouli S, Dormitzer PR, Settembre EC, Sealy RE, Wong S, Young NS, Sun Y, Tang L, Cotton A,
et al. Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease. Vaccines. 2021; 9(8):860.
https://doi.org/10.3390/vaccines9080860
Chicago/Turabian Style
Penkert, Rhiannon R., Sumana Chandramouli, Philip R. Dormitzer, Ethan C. Settembre, Robert E. Sealy, Susan Wong, Neal S. Young, Yilun Sun, Li Tang, Alyssa Cotton,
and et al. 2021. "Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease" Vaccines 9, no. 8: 860.
https://doi.org/10.3390/vaccines9080860
APA Style
Penkert, R. R., Chandramouli, S., Dormitzer, P. R., Settembre, E. C., Sealy, R. E., Wong, S., Young, N. S., Sun, Y., Tang, L., Cotton, A., Dowdy, J., Hayden, R. T., Hankins, J. S., & Hurwitz, J. L.
(2021). Novel Surrogate Neutralizing Assay Supports Parvovirus B19 Vaccine Development for Children with Sickle Cell Disease. Vaccines, 9(8), 860.
https://doi.org/10.3390/vaccines9080860